Prostate Specific Antigen anticorps (N-Term)
Aperçu rapide pour Prostate Specific Antigen anticorps (N-Term) (ABIN7598882)
Antigène
Voir toutes Prostate Specific Antigen (PSA) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- N-Term
-
Fonction
- Anti-PSA (Prostate-specific antigen)
-
Specificité
- PSA (Prostate-specific antigen)
-
Immunogène
- Peptide derived from N-terminal sequence of human PSA. Antibody recognizes the epitope between Arg77 -Gln88.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- +2 °C to +8 °C
-
-
- Prostate Specific Antigen (PSA)
-
Autre désignation
- PSA
-
Sujet
- PSA represents a prostate cancer protein marker, strongly expressed in both normal and neoplastic prostatic tissue. This protein is expressed at lower levels also in in breast tumors, endometrium, or renal cell carcinomas. Together with Prostate-Specific Acid Phosphatase (PSAP), PSA expression is detected in blood samples and/or prostate tissue-related biopsies, in order to confirm the prostatic origin of metastatic carcinoma.
-
UniProt
- P07288
-
Pathways
- Système du Complément
Antigène
-